Globe Life Q4 health net sales at United American Division surge to USD 77 million, up over 2.5 times

Reuters
02/05
Globe Life Q4 health net sales at <a href="https://laohu8.com/S/UAMA">United American</a> Division surge to USD 77 million, up over 2.5 times

Globe Life Inc. reported its fourth quarter (Q4) 2025 earnings, highlighting several key financial and business updates. Net operating income, a non-GAAP financial measure used by the company to evaluate performance, reached USD 84.75 million in Q4 2025. Insurance underwriting income for the full year ended December 31, 2025, was USD 18.82 per share. In terms of business segment performance, the Direct to Consumer Division recorded a 24% increase in life net sales over the year-ago quarter. The United American Division's health net sales grew by more than two and a half times, reaching approximately USD 77 million for the quarter. During the quarter, Globe Life repurchased 1.3 million shares of its common stock. For the year ending December 31, 2026, the company projects net operating income between USD 14.95 and USD 15.65 per diluted common share, reflecting an increase from previous guidance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Globe Life Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DA78302) on February 04, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10